Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
| Risk | Very High | Very High | 
| Rating | - | 5.0 | 
| Min SIP Amount | ₹100 | ₹100 | 
| Expense Ratio | 0.93 | 1.36 | 
| NAV | ₹9.35 | ₹201.70 | 
| Fund Started | 19 Sep 2024 | 07 May 2007 | 
| Fund Size | ₹259.94 Cr | ₹84854.73 Cr | 
| Exit Load | - | Exit load of 1% if redeemed within 1 year. | 
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
| 1 Year | -2.05% | 8.25% | 
| 3 Year | - | 26.57% | 
| 5 Year | - | 30.01% | 
1 Year
3 Year
5 Year
| Equity | 100.25% | 93.60% | 
| Cash | -0.25% | 6.40% | 
Equity
Cash
| Top 10 Holdings | 
 | 
 | 
Top 10 Holdings
| Name | Assets | 
|---|---|
| Max Financial Services Ltd. | 4.93% | 
| Max Healthcare Institute Ltd. | 4.80% | 
| Suzlon Energy Ltd. | 4.01% | 
| BSE Ltd. | 3.90% | 
| Solar Industries India Ltd. | 3.66% | 
| Coforge Ltd. | 3.55% | 
| Fortis Healthcare Ltd. | 3.31% | 
| One97 Communications Ltd. | 3.28% | 
| SRF Ltd. | 3.24% | 
| HDFC Asset Management Company Ltd. | 3.15% | 
| Name | Assets | 
|---|---|
| Max Financial Services Ltd. | 4.76% | 
| Balkrishna Industries Ltd. | 3.54% | 
| Indian Bank | 3.26% | 
| Fortis Healthcare Ltd. | 3.18% | 
| AU Small Finance Bank Ltd. | 3.16% | 
| Coforge Ltd. | 2.93% | 
| The Federal Bank Ltd. | 2.91% | 
| Hindustan Petroleum Corporation Ltd. | 2.90% | 
| Glenmark Pharmaceuticals Ltd. | 2.87% | 
| Ipca Laboratories Ltd. | 2.80% | 
| Name | Satish Dondapati | Chirag Setalvad | 
| Start Date | 28 Jul 2025 | 28 Jun 2014 | 
Name
Start Date
| Description | The scheme seeks to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking errors. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. | 
| Launch Date | 19 Sep 2024 | 07 May 2007 | 
Description
Launch Date